In many states, regulations require that cannabis testing laboratories be accredited to ISO/IEC 17025 in order to operate. This requirement is not ubiquitous, however, and in the absence of federal requirements for cannabis testing, states where cannabis products are legal demonstrate significant variability in how those products are regulated. As a result, many cannabis testing labs have taken it upon themselves to implement quality assurance measures that go beyond the requirements in their state. Accreditation to ISO/IEC 17025 is a widely recognized indicator of competence within the cannabis testing space, so labs seeking more rigorous quality parameters often voluntarily apply for accreditation through A2LA. Representatives from two such labs: Kristen Goedde of Trichome Analytical in new Jersey, and Jessica Alexander of Land & Seas Laboratory in Alaska, each kindly answered our questions about why they chose to have their laboratories accredited by A2LA, even though it was not mandatory in their respective states.
With the cannabis industry continuing to grow throughout the US, A2LA has dedicated itself to supporting quality in cannabis labs as they work to ensure access to safe, accurately labeled cannabis products. A2LA’s dedicated cannabis accreditation team is involved in industry groups, provides educational content to cannabis labs, and even makes recommendations on new legislation. Each laboratory we accredit has its own unique history and a distinct journey to accreditation, but the value of ISO/IEC 17025 is universal within the cannabis industry. For this Cannabis Customer Q&A, Greg Michaud, CEO of Viridis Laboratories, spoke with us about the value of ISO/IEC 17025 accreditation and why Viridis chose A2LA as their accreditation provider.
A2LA is pleased to announce the accreditation of Cannalytics, LLC to ISO/IEC 17025:2017 for cannabis testing. Cannalytics, based in San Juan, Puerto, was accredited by A2LA in December 2020 and is the first cannabis testing laboratory accredited in Puerto Rico. Cannalytics is led by professionals with extensive laboratory experience in related fields, giving them the skills required to excel in cannabis testing. Owner and Director Jorge H. Diaz, MT (ASCP) and his team pursued accreditation with A2LA to establish themselves as quality leaders in the fast-expanding cannabis industry and to support a safe and consistent medical cannabis supply in Puerto Rico.
Colorado was among the first states to legalize cannabis products for medical use and the second state to legalize recreational cannabis use for adult use. As a result, Colorado has one of the best-established cannabis infrastructures in the US and boasts many highly trusted cannabis testing laboratories. Del Kreiser, Marketing Manager for Botanacor, kindly spoke with Accreditation Supervisor Anna Williams about their role in the cannabis industry and how accreditation plays a part in their ongoing commitment to quality.
In a sweeping show of popular support, New Jersey, Arizona, Montana, and South Dakota have all voted to legalize the recreational use of marijuana, and Mississippi has voted to legalize marijuana for medical use. In all five states, the decision was made by ballot measure. These five states are only the latest in a massive and relatively rapid nationwide shift in support of marijuana access, leaving Idaho as the only state in the US where no form of cannabis (hemp or marijuana) is legal for any application. These ballot measures are expected to have a significant impact on the cannabis industry in the states where they passed, and to influence cannabis legislation in neighboring states.
As more and more states across America legalize cannabis, it is important to ensure that the public can be confident in the end product that they use. A2LA is engaged in ensuring quality and compliance in this industry, as evidenced by our ever-growing presence in industry groups, influence on state regulations, strategic partnerships, and the educational content we provide in-person and online. Anna Williams, an Accreditation Supervisor at A2LA, interviewed Timothy Schnupp, Laboratory Director for Pinnacle CT Labs in Westminster, Maryland, in order to understand how they are combating the vaping crisis by providing ISO/IEC 17025 accredited testing for vitamin E acetate.
The A2LA-accredited Demeter Laboratory was recently awarded a unique contract as part of Oklahoma’s comprehensive plan to ensure uniform quality in medical cannabis products. In 2019 Demeter was the first medical cannabis laboratory in the state of Oklahoma to be accredited to ISO/IEC 17025 by A2LA, distinguishing them as an industry leader in the state and affirming the capabilities and competency of their laboratory. Now, the Oklahoma Medical Marijuana Authority (OMMA) has contracted Demeter Laboratory to evaluate all other cannabis labs in the state for their adherence to OMMA rules and regulations, and to conduct secondary testing on products submitted to other labs. As part of this contract, Demeter will no longer provide commercial testing of cannabis products, and will dedicate their facility and staff exclusively to OMMA’s quality assurance program.
A2LA is pleased to announce the accreditation of ECC Test Lab to ISO/IEC 17025:2017 for cannabis testing. East Coast Cannalytics (dba ECC Test Lab), based in Blacksburg, VA, is the first cannabis testing laboratory accredited to the standard in the state by A2LA.
A2LA is pleased to announce the accreditation of Trichome Analytical to ISO/IEC 17025:2017 for cannabis testing. Trichome, based in Mount Laurel, NJ, is the first cannabis testing laboratory accredited to the standard in the state.
A2LA is pleased to announce the accreditation of Viridis Laboratories to ISO/IEC 17025:2017 for cannabis testing. Viridis, based in Lansing, MI, is A2LA’s first cannabis testing laboratory accredited in the State of Michigan.